Connor, Clark & Lunn Investment Management Ltd. Cyma Bay Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$7.47 - $10.95 $1.77 Million - $2.59 Million	-236,367 Reduced 69.39%	104,271 $1.14 Million
Q1 2023 May 09, 2023	BUY	$5.88 - $9.59 $296,728 - $483,949	50,464 Added 17.39%	340,638 $2.97 Million
Q4 2022 Feb 10, 2023	BUY	$3.22 - $6.27 $80,860 - $157,452	25,112 Added 9.47%	290,174 $1.82 Million
Q3 2022 Nov 10, 2022	BUY	$2.77 - $4.25 $330,042 - $506,383	119,149 Added 81.66%	265,062 $928,000
Q2 2022 Aug 05, 2022	BUY	$1.72 - $3.39 $135,350 - $266,765	78,692 Added 117.06%	145,913 $430,000
Q1 2022 May 12, 2022	BUY	$2.77 - $3.64 $186,202 - $244,684	67,221 New	67,221 $209,000
Q1 2021 May 13, 2021	SELL	$4.23 - $6.55 $375,780 - $581,882	-88,837 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $547,541 - $862,879	-95,557 Reduced 51.82%	88,837 $510,000
Q3 2020 Nov 12, 2020	SELL	$3.32 - $7.24 $202,307 - $441,176	-60,936 Reduced 24.84%	184,394 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $4.25 $181,544 - $547,208	128,755 Added 110.45%	245,330 $856,000
Q1 2020 May 13, 2020	BUY	$1.25 - $2.02 $111,156 - $179,628	88,925 Added 321.61%	116,575 $172,000
Q4 2019 Feb 12, 2020	BUY	$1.33 - $5.93 $36,774 - $163,964	27,650 New	27,650 $54,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account